AusperBio to Showcase Long-Term AHB-137 Chronic Hepatitis B Data in Late-Breaking Oral Presentations at AASLD The Liver Meeting® 2026

Two abstracts on long-term follow-up data of AHB-137 treatment for chronic hepatitis B have been selected for late-breaking oral presentations at The Liver Meeting® 2026.